Ignite Creation Date:
2024-05-05 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00480363
Status:
COMPLETED
Last Update Posted:
2013-07-31
First Post:
2007-05-28
Brief Title:
QUIREDEX Revlimid Lenalidomide and Dexamethasone ReDex Treatment Versus Observation in Patients With Smoldering Multiple Myeloma With High Risk of Progression
Sponsor:
PETHEMA Foundation
Organization:
PETHEMA Foundation
Organization Data
Organization:
PETHEMA Foundation
Class:
OTHER
Study ID:
2007-000649-36
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
PETHEMA Foundation
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Pethema
Old Organization:
Pethema
Collaborators
| Name | Class |
|---|---|
| Celgene Corporation | INDUSTRY |